An Israeli pharmaceutical manufacturer that benefits from selling to the captive Palestinian market.
Taro is a research-based international pharmaceutical company that develops pharmaceuticals for markets in the U.S., Canada, Israel, and other countries around the world.
According to Who Profits, Taro benefits from selling to the captive Palestinian market. Israeli policies and regulations hinder the import of raw materials to occupied Palestine; place prohibitions and high costs on exports and deliveries to the occupied Palestinian territory; and exclude Arab markets, while ensuring that Israeli companies like Taro enjoy easy access to the Palestinian market. Free of customs taxes, searches at military checkpoints, and other burdensome requirements enforced on the Palestinian market, Taro faces little to no competition.